$500 – $1,000 Paid Clinical Trials

440 studies

Short outpatient Phase 1 studies and multi-visit observational studies often compensate in the $500–$1,000 range.

Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.

Showing 261–280 of 440 studies

$500 – $1,000 Paid Clinical Trials

A Phase 1 Study of FZ008-145 in Healthy Subjects.

Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

I.V. Selonabant in Healthy Adult Subjects

A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085

A Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult Participants

Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers

A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease

Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets

A First-in-Human Single and Multiple Ascending Dose Study of MT-701

A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants

A Study of Elenestinib in Healthy Adult Female Participants

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcutaneous Administration in Healthy Volunteers/Overweight or Obese Volunteers

A Study of TJ101 Injection Before and After CMC Change Following Subcutaneous Injection in Healthy Adult Male Subjects in China

A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

First-In-Human Study to Evaluate Single and Multiple Ascending Doses of JUV-161 in Healthy Adult Volunteers

To Evaluate the Adhesion of TK-254RX on Healthy Participants

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

Study of CM383 in Healthy Subjects